Skip to main content

Viskase Holdings, Inc.

corporate_fare Company Profile

Viskase Holdings, Inc.

Enzon Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the sale of its patented drug product, PegIntron. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey.

Exchange: OTCSector: Life Sciences

show_chartPrice Chart

Loading chart...

feed ENZN - Latest Insights

ENZN
Mar 27, 2026, 7:48 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Carl Icahn's Entities Consolidate 93.7% Control of Viskase Holdings Post-Merger, Appoint Affiliates to Board
Sentiment: Neutral
View Wiseek Article
ENZN
Mar 26, 2026, 5:24 PM EDT
Filing Type: 8-K
Importance Score:
9
Viskase Holdings Completes Transformational Merger with Viskase Companies, Overhauls Leadership
Sentiment: Neutral
View Wiseek Article
ENZN
Mar 25, 2026, 8:38 AM EDT
Filing Type: 425
Importance Score:
7
Enzon Pharmaceuticals Completes Series C Preferred Stock Exchange Offer
Sentiment: Neutral
View Wiseek Article
ENZN
Mar 25, 2026, 8:36 AM EDT
Filing Type: 8-K
Importance Score:
7
Enzon Pharmaceuticals Completes Series C Preferred Stock Exchange Offer
Sentiment: Positive
View Wiseek Article
ENZN
Mar 24, 2026, 8:35 AM EDT
Filing Type: SC TO-I/A
Importance Score:
8
Enzon Pharmaceuticals Announces 1-for-100 Reverse Stock Split Effective Today, Paving Way for Merger
Sentiment: Negative
View Wiseek Article
ENZN
Mar 24, 2026, 8:30 AM EDT
Filing Type: 425
Importance Score:
8
Enzon Pharmaceuticals Implements 1-for-100 Reverse Stock Split, Critical for Viskase Merger
Sentiment: Neutral
View Wiseek Article
ENZN
Mar 24, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Enzon Pharmaceuticals Announces 1-for-100 Reverse Stock Split Effective March 24th, Prepares for Viskase Merger
Sentiment: Neutral
View Wiseek Article
ENZN
Mar 19, 2026, 4:07 PM EDT
Filing Type: SC TO-I/A
Importance Score:
7
Enzon Extends Preferred Stock Exchange Offer Again Amidst Less Than 1% Participation
Sentiment: Negative
View Wiseek Article
ENZN
Mar 16, 2026, 4:10 PM EDT
Filing Type: 425
Importance Score:
7
Enzon Pharmaceuticals Extends Series C Preferred Stock Exchange Offer to March 19
Sentiment: Neutral
View Wiseek Article
ENZN
Mar 11, 2026, 8:36 AM EDT
Filing Type: 425
Importance Score:
7
Enzon Pharmaceuticals Extends Section 382 Rights Agreement and Preferred Stock Exchange Offer Amidst Viskase Merger
Sentiment: Neutral
View Wiseek Article
ENZN
Mar 11, 2026, 8:31 AM EDT
Filing Type: SC TO-I/A
Importance Score:
7
Enzon Extends Preferred Stock Exchange Offer Again Amidst Less Than 1% Participation
Sentiment: Negative
View Wiseek Article
ENZN
Mar 09, 2026, 4:13 PM EDT
Filing Type: 425
Importance Score:
7
Enzon Pharmaceuticals Extends Preferred Stock Exchange Offer Again Amidst Viskase Merger Process
Sentiment: Negative
View Wiseek Article
ENZN
Mar 02, 2026, 4:56 PM EST
Filing Type: 10-K
Importance Score:
9
Enzon Pharmaceuticals Reports Significant 2025 Net Loss Amidst Transformational Merger with Viskase
Sentiment: Negative
View Wiseek Article
ENZN
Feb 27, 2026, 8:30 AM EST
Filing Type: SC TO-I/A
Importance Score:
8
Enzon Extends Preferred Stock Exchange Offer Amid Extremely Low Participation
Sentiment: Negative
View Wiseek Article
ENZN
Feb 26, 2026, 4:05 PM EST
Filing Type: SC 14F1
Importance Score:
8
Enzon Pharmaceuticals Details Post-Merger Board and Executive Leadership Changes
Sentiment: Neutral
View Wiseek Article
ENZN
Feb 11, 2026, 5:14 PM EST
Filing Type: 8-K
Importance Score:
9
Stockholders Approve 1-for-100 Reverse Stock Split and Viskase Merger Agreement
Sentiment: Neutral
View Wiseek Article
ENZN
Jan 30, 2026, 6:02 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Carl Icahn Affiliates Approve Viskase Merger and Charter Amendment
Sentiment: Positive
View Wiseek Article
ENZN
Jan 30, 2026, 4:38 PM EST
Filing Type: 424B3
Importance Score:
9
Enzon Finalizes Terms for Merger with Viskase, Confirming 1-for-100 Reverse Split and Significant Dilution
Sentiment: Negative
View Wiseek Article
ENZN
Jan 30, 2026, 3:13 PM EST
Filing Type: S-4/A
Importance Score:
7
Enzon Commences Exchange Offer for Preferred Stock Ahead of Viskase Merger
Sentiment: Neutral
View Wiseek Article
ENZN
Jan 28, 2026, 5:01 PM EST
Filing Type: S-4
Importance Score:
9
Enzon Files S-4 for Merger with Viskase, Proposing 1-for-100 Reverse Stock Split and Significant Dilution for Existing Common Shareholders
Sentiment: Negative
View Wiseek Article